Editor in Chief Dr KK Aggarwal, Padma Shri Awardee                                                                               Dated:14 July,2020

Telangana: RT-PCR not done on those who test antigen negative

HYDERABAD: While Telangana, after much delay, has started rapid antigen testing, it is not following the protocol strictly. Though the ICMR has suggested that those who test negative in an antigen test, need to undergo a RT-PCR test, the government has decided to ask symptomatic people to go into isolation, instead of testing them again. Incidentally, Bollywood star Aishwarya Rai tested negative in the rapid antigen test, but turned positive in the RT-PCR test.
The state’s decision has left experts wary as they say more caution is the need of the hour. They insist that antigen followup should be made strict, even as the health department has not mandated the RT-PCR test for those who report negative in antigen test. During the antigen tests done across Greater Hyderabad and Rangareddy and Medchal districts, patients who tested negative aren’t being made to undergo the followup RT-PCR test, but being asked to do self-quarantine at home, if they are symptomatic. ....read more

CMAAO Coronavirus Facts and Myth Buster: Lab Testing

973: IMA-CMAAO Webinar on “COVID testing” 11th July, 2020 4-5pm
Participants: Dr KK Aggarwal, President CMAAO, Dr RV Asokan, Hony Secretary General IMA, Dr Ramesh K Datta, Hony Finance Secretary IMA, Dr Jayakrishnan Alapet, Dr Brijendra Prakash, Dr Girdhari Kanuga, Dr Sanchita Sharma,Faculty: Dr Shalabh Malik, National Head Microbiology, Dr Lal Path Labs
Key points from the discussion:The coronavirus is a new virus with no proven therapy or a vaccine as of date. Diagnostic testing becomes an important tool for management of patient with COVID-19. ,Lab test options available: Molecular, antigen (point of care test, CARD test) and antibody [rapid – not allowed in India so far, CLIA – automated platform, ELISA, IgG/IgM, total (combination of IgG and IgM)]....read more

World COVID Meter 13th July: India Number 3, 213 Countries Affected

Cases: 1M April 2, 2M April 15, 3M April 27, 4M May 8, 5M May 20, 6M May 30, 7M June 7, 8M June 15, 9M June 22, 10M June 29, 11M July 4, 12M July 10 ,Ground Zero: Wuhan - in live animal market or cafeteria for animal pathogens: 10th January; Total cases are based on RT PCR, 67% sensitivity ,Doubling time India 21 days, USA 33 days, Brazil 13 days, Russia 18 days, Spain 47 days, UK 35 days, Italy 55 days, France 49 days, Turkey 37 days ,Likely minimum deaths (571518 + 58926 x 15 == 8839) = 580356,Coronavirus Cases: 13,034,955,Deaths: 571,518,Recovered: 7,581,525....read more

Sewa the best dharma

Offering help is the best service to the humanity. As per Sikhism, Sewa (unconditional service), Simran (meditation) and Satsang (company of good people) constitute the trio to acquire happiness and spiritual health. In Sikhism, Sewa is the main path for acquiring spiritualism. In a Gurudwara, one even offers sewa by cleaning the shoes of others or by cleaning the entry paths to the Gurudwara.
Offering help covers all the paths of being a Satyugi, i.e., truthfulness, unconditional hard work, purity of mind and finally, Daya and Daan. When you offer help, you always do it in a positive state of mind and it involves hard work, mercy and charity. ....read more

Video of The day

In COVID 19 try this antibiotic also



Healthcare News Monitor
World's first Covid-19 vaccine? Russia successfully completes clinical trials
Live mint

After over six months of novel coronavirus outbreak, which has infected more than 12 million people and killed over 500,000 all over the world, the clinical trials of the purportedly world's first coronavirus vaccine have been successfully completed. ,The clinical trials of the world's first coronavirus vaccine on volunteers at Sechenov First Moscow State Medical University has been successfully completed, Vadim Tarasov, the director of the Institute for Translational Medicine and Biotechnology, according to Russian news agency Sputnik, adding that the first group of volunteers would be discharged on 15 July and the second on 20 July.

India to reduce over-dependence on Chinese pharmaceutical raw materials

India is considering importing certain active pharmaceutical ingredients (APIs) and intermediaries from alternative sources such as the United States, Italy, Singapore and Hong Kong, leading to ramping up domestic capacity in a bid to reduce dependence on China, two officials aware of development said.
Over 63 per cent of India’s pharmaceutical imports are API and intermediates, and almost 70 per cent of it comes from China. Dependence on a single country for such crucial thing is not prudent in India’s national interest, hence there is a need to diversify its sourcing and develop domestic capacity, the officials said requesting anonymity.

Delhi: Doctor, associate arrested for issuing fake medical certificates to help criminals get bail
India Today

The team of STARS-2, Crime Branch has arrested one doctor Gajender Kumar Nayyar and his associate Mukesh Sangwan for their involvement in issuing fake medical certificates to accused, convicts. They were also involved in issuing the fake medical documents to family members of accused and convicts for extraneous consideration to facilitate them in obtaining favorable orders of bail, interim bail and suspension of sentence. Accused Mukesh Sangwan used to provide clients to the doctor.
On June 29, High Court of Delhi passed an order on bail application in case of Abdul Rehman Nawali Vs State to conduct an inquiry into the allegations raised by the prosecution that Dr Gajender Kumar Nayyar is issuing fake medical certificates. During the enquiry, it was found that Dr Gajender Kumar Nayyar is registered with Delhi Medical Council and is under suspension till November 29, 2020 for professional misconduct since March 29, 2019. During the suspension time he has been issuing medical certificates. A case under appropriate sections was registered at PS Crime Branch, Delhi and investigation was taken up.

COVID-19 vaccine: India to begin human clinical trials; Patna AIIMS selects 18 volunteeers

After Russia became the first country to successfully conclude human trials for the world's premier coronavirus vaccine, India is set to begin the human clinical trials for vaccines against the SARS-CoV-2, the virus that causes the dreaded coronavirus disease (COVID-19). For the purpose of the trials, the All India Institute of Medical Sciences (AIIMS) in Patna has selected 18 volunteers on whom the vaccine trails will be conducted. ,According to sources, the hospital authority is set to begin the human trials of the vaccine from today (i.e. July 13, Monday). ,Till now, only the Bharat Biotech International Ltd and the Zydus Cadila pharmaceutical companies' indigenously developed vaccine prototypes have got an approval for the human trials from the Drugs Controller General of India.